Answers are grounded in this paper and cite their sources.
Explores optimal abatement effort in corporations amid carbon price uncertainty, suggesting strategies for active investment.
This study formulates a corporate abatement decision problem under carbon price uncertainty as a continuous-time stochastic control model. To this end, the carbon price is modeled as a geometric Brownian motion, while abatement capacity is accumulated through costly effort and depreciates over time. Specifically, the firm chooses its abatement effort to maximize expected discounted profits while accounting for allowance purchasing costs, compliance-related penalties, abatement costs, and potential revenues from surplus allowances. The paper contributes by integrating stochastic carbon prices, endogenous abatement-capacity accumulation, allowance-shortage/allowance-surplus asymmetry, and surplus allowance monetization into a unified corporate abatement framework. Applying the dynamic programming principle, the associated Hamilton–Jacobi–Bellman equation is derived, and the bounded optimal abatement effort is characterized in feedback form. Since the resulting nonlinear HJB equation generally does not admit a closed-form solution, a finite-difference scheme with damped policy iteration is used for numerical analysis. The results show that optimal abatement effort is strongly state-dependent. Higher carbon prices strengthen abatement incentives in the allowance-shortage region, whereas effort declines sharply after reaching allowance neutrality if surplus allowances cannot be monetized. Moreover, partial monetization of surplus allowances significantly increases abatement effort in the surplus region and can shift firms’ behavior from passive compliance to active low-carbon investment. Overall, these findings suggest that surplus allowance monetization plays an important role in sustaining firms’ abatement incentives under carbon price uncertainty.
No takes yet. Share an insight, caveat, or question.
Haichao Yang (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: